Answers are grounded in this paper and cite their sources.
Literature review examines NAFLD prevalence and identifying factors in normal-weight and overweight individuals.
Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease worldwide, affecting 20-40% of the population, and its prevalence continues to steadily increase. However, some individuals with overweight and obesity maintain normal intrahepatic fat content, while others with normal weight develop NAFLD even in the absence of metabolic risk factors. Therefore, recent terminology has introduced a distinct NAFLD phenotype in individuals with normal body weight, the pathophysiology and clinical manifestations of which remain insufficiently studied. This review summarizes literature and original data on the prevalence of NAFLD phenotypes in individuals with normal and increased body weight, risk factors, clinical and pathogenetic features, and diagnostic approaches. There is a need to develop screening algorithms that are less dependent on BMI and liver transaminase levels, to implement more accurate treatment strategies based on the pathogenesis of the disease, and to include individuals with normal body weight in NAFLD-related clinical trials to identify factors modulating the risk of liver steatosis, including in the absence of clinically significant metabolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Shevlyukovа et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: